[ET Net News Agency, 20 July 2026] HANSOH PHARMA (03692) rose 3.2% to HK$32.82.
It hits an intra-day high of HK$32.82, breaking above the 50-D SMA of HK$31.832, and an intra-day low of HK$31.98. The total shares traded was 2.21 million, with a value of HK$71.08m. The active buy/sell ratio is 59:41, with net buying turnover of HK$6.94m. UBS accounts for greatest net responsive buying turnover of HK$2.38m, with volume weighted average price of HK$32.474. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$3.78m, with volume weighted average price of HK$32.451.
The Hang Seng Index now rose 497 points, or 2% to 25,059; the Hang Seng China Enterprises Index now rose 210 points, or 2.6% to 8,346.
Basic Information| Nominal | 32.820 | % Chg | +3.21% |
| High | 32.820 | Low | 31.980 |
| Shares Tr | 2.21m | Turnover | 71.08m |
| 10-D SMA | 32.344 | %H.V | 50.097 |
| 20-D SMA | 31.340 | VWAP | 32.222 |
| 50-D SMA | 31.832 | RSI14 | 55.908 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 59:41, with net buying turnover of HK$6.94m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 32.82 | +3.21 |
| SIHUAN PHARM (00460) | 0.88 | +2.33 |
| GRAND PHARMA (00512) | 5.29 | +2.52 |
| SBP GROUP (01177) | 5.11 | +2.61 |
| HENGRUI PHARMA (01276) | 56.95 | +3.45 |
| LIVZON PHARMA (01513) | 26.90 | +2.59 |
| LUYE PHARMA (02186) | 2.11 | +2.43 |
| FOSUN PHARMA (02196) | 16.53 | +1.91 |
| SH PHARMA (02607) | 12.10 | +0.25 |
| CHINARES PHARMA (03320) | 4.82 | +2.34 |
(ed)
